YONGJINSAM GOLD
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- YONGJINSAM GOLD
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Health Care Supplement
Biomedgenomics Co., Ltd.
- Verified Certificate
-
3
Product name | YONGJINSAM GOLD | Certification | FDA |
---|---|---|---|
Category | Health Care Supplement | Ingredients | - |
Keyword | korea red ginseng , wild ginseng beverage , health functional foods , immune booster | Unit Size | 11.3 * 14.5 * 11.3 cm |
Brand name | YONGJINSAM GOLD | Unit Weigh | 783 g |
origin | South Korea | Stock | - |
Supply type | - | HS code | 0101211000 |
Product Information
YONGJINSAM Gold(Capsule) is
a special red ginseng product that enhances wild ginseng saponin Rg5
with high physiological activity by special manufacturing method
(Korea Patent 0754767).
It was acquired patents in Korea, USA, Japan, China, UK, Canada and Russia, and currently holds patents in three countries: Korea, USA, Japan.
Also received US FDA approval.
This is a product that researched and developed the six-year-old korean ginseng for 6 years.
Other important saponins (Rg3, Ro, Re, Rc, etc.),
which are very useful for liver, hypertension,
and diabetes, are relatively high(4 ~ 17 times more) in red ginseng
compared to other famous products.
It is a very good red ginseng product that inhanced especially immunity and anticancer efficacy In nutrition and function.
Wild ginseng saponin Rg5 enhances immunity and anticancer effect.
It has been strengthened in yongjinsam ginseng powder.
* Rg5 : The best saponin exist only in wild ginseng.
Excellent immune enhancement and anti cancer effect.
(source : journal of the Goryeo ginseng society 39(2) 125-134 1226-8453 KCI)
http://web.tradekorea.com/tradekorea/editor/upload_image/2021/03/20210303_134050235_14345.jpg[special point]
It is an upgrade of yongjinsam powder.
It's convenient to take because of capsule form, and contains wild ginseng saponin Rg5, and high quality.
Wild ginseng saponin Rg5 enhances immunity and anticancer effect.
* Rg5 : The best saponin exist only in wild ginseng.
Excellent immune enhancement and anti cancer effect.
(source : journal of the Goryeo ginseng society 39(2) 125-134 1226-8453 KCI)
- Product Info Attached File
- Verified Certificate
-
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
Biomedgenomics Co., Ltd.
-
3
- President
- CHUNG YOU SUP
- Address
- 444 Dongbaekjukjeon-daero Giheung-gu Yongin-si Gyeonggi, Giheung-gu, Yongin-si, Gyeonggi-do, Korea
- Product Category
- Health Care Supplement
- Year Established
- 2006
- No. of Total Employees
- 1-50
- Company introduction
-
Biomedgenomics.Co.Ltd., is the professionalHealth Functional Food company, founded in 2006. The CEO of the company, YouSupChung who has 33 years of career with professional researcher at Korea leadingpharmaceutical companies, developed the special red ginseng ‘Yongjinsam’product, which included Wild Saponin (*Rg5) at the highest level in Koreathrough six years of research.
Yongjinsam firstly obtained patents in sevencountries, including Korea, USA, Japan, China, England, Canada, and Russia, andmaintains patents in three countries _ Korea, USA, Japan _ and has beenapproved by the U.S. FDA.
It is a company that manufactures and sellsYongjinsam and other healthy foods for 15 years.
*Rg5: the ingredient that boost the immunity, which is included inWild Ginseng.
(Wild ginseng: Wild ginseng is a ginseng that naturally grows onmountains, and its adaptability and utility are similar to ginseng, but itsmedicinal effects are superior)
[Doctor of Pharmacy Yousup-Chung, Academics and Experiences]
* Graduated from Seoul National University College of Pharmacy
* Doctor of Pharmacy, Graduate School, Seoul National University
* Post-Doc. Of Chemistry, University of Pennsylvania, USA
* Handok Pharmaceutical Science Department, Quality Control Department, Synthesis Department
* Managing Director of Choongwae pharmaceutical Research Institute, Director of C & C New Drug Research Institute
* Director, Hanlim Pharmaceutical Research Center
* Currently, CEO of Biomedgenomics (2006~ )
- Main Markets
-
Singapore
U.S.A
Viet Nam
- Main Product